Global Targeted Antitumor Drugs Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-targeted-antitumor-drugs-market-research-report-2024status-n-outlook_en.gif)
Report Overview
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
This report provides a deep insight into the global Targeted Antitumor Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Targeted Antitumor Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Targeted Antitumor Drugs market in any manner.
Global Targeted Antitumor Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Celgene
Novartis
Johnson & Johnson
Lilly
AstraZeneca plc.
Betta Pharmaceuticals
Shanghai Henlius Biopharmaceutical
Innovent Biologics
Nanjing Shunxin Pharmaceuticals
CSPC OUYI Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Yaopharma
Lianyungang Runzhong Pharmaceutical
Market Segmentation (by Type)
Injection
Tablet
Others
Market Segmentation (by Application)
Lung Cancer
Lymphoma
Breast Cancer
Leukaemia
Prostate Cancer
Multiple Bone Marrow Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Antitumor Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
This report provides a deep insight into the global Targeted Antitumor Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Targeted Antitumor Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Targeted Antitumor Drugs market in any manner.
Global Targeted Antitumor Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Celgene
Novartis
Johnson & Johnson
Lilly
AstraZeneca plc.
Betta Pharmaceuticals
Shanghai Henlius Biopharmaceutical
Innovent Biologics
Nanjing Shunxin Pharmaceuticals
CSPC OUYI Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Yaopharma
Lianyungang Runzhong Pharmaceutical
Market Segmentation (by Type)
Injection
Tablet
Others
Market Segmentation (by Application)
Lung Cancer
Lymphoma
Breast Cancer
Leukaemia
Prostate Cancer
Multiple Bone Marrow Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Targeted Antitumor Drugs Market
- Overview of the regional outlook of the Targeted Antitumor Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Antitumor Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Targeted Antitumor Drugs
1.2 Key Market Segments
1.2.1 Targeted Antitumor Drugs Segment by Type
1.2.2 Targeted Antitumor Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARGETED ANTITUMOR DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Targeted Antitumor Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Targeted Antitumor Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARGETED ANTITUMOR DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Targeted Antitumor Drugs Sales by Manufacturers (2019-2024)
3.2 Global Targeted Antitumor Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Targeted Antitumor Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Targeted Antitumor Drugs Sales Sites, Area Served, Product Type
3.6 Targeted Antitumor Drugs Market Competitive Situation and Trends
3.6.1 Targeted Antitumor Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Targeted Antitumor Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TARGETED ANTITUMOR DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Targeted Antitumor Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARGETED ANTITUMOR DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TARGETED ANTITUMOR DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Antitumor Drugs Sales Market Share by Type (2019-2024)
6.3 Global Targeted Antitumor Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Targeted Antitumor Drugs Price by Type (2019-2024)
7 TARGETED ANTITUMOR DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Antitumor Drugs Market Sales by Application (2019-2024)
7.3 Global Targeted Antitumor Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Targeted Antitumor Drugs Sales Growth Rate by Application (2019-2024)
8 TARGETED ANTITUMOR DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Targeted Antitumor Drugs Sales by Region
8.1.1 Global Targeted Antitumor Drugs Sales by Region
8.1.2 Global Targeted Antitumor Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Targeted Antitumor Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Targeted Antitumor Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Targeted Antitumor Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Targeted Antitumor Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Targeted Antitumor Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Targeted Antitumor Drugs Basic Information
9.1.2 Roche Targeted Antitumor Drugs Product Overview
9.1.3 Roche Targeted Antitumor Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Targeted Antitumor Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Targeted Antitumor Drugs Basic Information
9.2.2 Celgene Targeted Antitumor Drugs Product Overview
9.2.3 Celgene Targeted Antitumor Drugs Product Market Performance
9.2.4 Celgene Business Overview
9.2.5 Celgene Targeted Antitumor Drugs SWOT Analysis
9.2.6 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Targeted Antitumor Drugs Basic Information
9.3.2 Novartis Targeted Antitumor Drugs Product Overview
9.3.3 Novartis Targeted Antitumor Drugs Product Market Performance
9.3.4 Novartis Targeted Antitumor Drugs SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Targeted Antitumor Drugs Basic Information
9.4.2 Johnson and Johnson Targeted Antitumor Drugs Product Overview
9.4.3 Johnson and Johnson Targeted Antitumor Drugs Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Lilly
9.5.1 Lilly Targeted Antitumor Drugs Basic Information
9.5.2 Lilly Targeted Antitumor Drugs Product Overview
9.5.3 Lilly Targeted Antitumor Drugs Product Market Performance
9.5.4 Lilly Business Overview
9.5.5 Lilly Recent Developments
9.6 AstraZeneca plc.
9.6.1 AstraZeneca plc. Targeted Antitumor Drugs Basic Information
9.6.2 AstraZeneca plc. Targeted Antitumor Drugs Product Overview
9.6.3 AstraZeneca plc. Targeted Antitumor Drugs Product Market Performance
9.6.4 AstraZeneca plc. Business Overview
9.6.5 AstraZeneca plc. Recent Developments
9.7 Betta Pharmaceuticals
9.7.1 Betta Pharmaceuticals Targeted Antitumor Drugs Basic Information
9.7.2 Betta Pharmaceuticals Targeted Antitumor Drugs Product Overview
9.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Product Market Performance
9.7.4 Betta Pharmaceuticals Business Overview
9.7.5 Betta Pharmaceuticals Recent Developments
9.8 Shanghai Henlius Biopharmaceutical
9.8.1 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Basic Information
9.8.2 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Overview
9.8.3 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Market Performance
9.8.4 Shanghai Henlius Biopharmaceutical Business Overview
9.8.5 Shanghai Henlius Biopharmaceutical Recent Developments
9.9 Innovent Biologics
9.9.1 Innovent Biologics Targeted Antitumor Drugs Basic Information
9.9.2 Innovent Biologics Targeted Antitumor Drugs Product Overview
9.9.3 Innovent Biologics Targeted Antitumor Drugs Product Market Performance
9.9.4 Innovent Biologics Business Overview
9.9.5 Innovent Biologics Recent Developments
9.10 Nanjing Shunxin Pharmaceuticals
9.10.1 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Basic Information
9.10.2 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Overview
9.10.3 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Market Performance
9.10.4 Nanjing Shunxin Pharmaceuticals Business Overview
9.10.5 Nanjing Shunxin Pharmaceuticals Recent Developments
9.11 CSPC OUYI Pharmaceutical
9.11.1 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Basic Information
9.11.2 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Overview
9.11.3 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Market Performance
9.11.4 CSPC OUYI Pharmaceutical Business Overview
9.11.5 CSPC OUYI Pharmaceutical Recent Developments
9.12 Qilu Pharmaceutical
9.12.1 Qilu Pharmaceutical Targeted Antitumor Drugs Basic Information
9.12.2 Qilu Pharmaceutical Targeted Antitumor Drugs Product Overview
9.12.3 Qilu Pharmaceutical Targeted Antitumor Drugs Product Market Performance
9.12.4 Qilu Pharmaceutical Business Overview
9.12.5 Qilu Pharmaceutical Recent Developments
9.13 Shenzhen Salubris Pharmaceuticals
9.13.1 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Basic Information
9.13.2 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Overview
9.13.3 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Market Performance
9.13.4 Shenzhen Salubris Pharmaceuticals Business Overview
9.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments
9.14 Yaopharma
9.14.1 Yaopharma Targeted Antitumor Drugs Basic Information
9.14.2 Yaopharma Targeted Antitumor Drugs Product Overview
9.14.3 Yaopharma Targeted Antitumor Drugs Product Market Performance
9.14.4 Yaopharma Business Overview
9.14.5 Yaopharma Recent Developments
9.15 Lianyungang Runzhong Pharmaceutical
9.15.1 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Basic Information
9.15.2 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Overview
9.15.3 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Market Performance
9.15.4 Lianyungang Runzhong Pharmaceutical Business Overview
9.15.5 Lianyungang Runzhong Pharmaceutical Recent Developments
10 TARGETED ANTITUMOR DRUGS MARKET FORECAST BY REGION
10.1 Global Targeted Antitumor Drugs Market Size Forecast
10.2 Global Targeted Antitumor Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Targeted Antitumor Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Targeted Antitumor Drugs Market Size Forecast by Region
10.2.4 South America Targeted Antitumor Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Targeted Antitumor Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Targeted Antitumor Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Targeted Antitumor Drugs by Type (2025-2030)
11.1.2 Global Targeted Antitumor Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Targeted Antitumor Drugs by Type (2025-2030)
11.2 Global Targeted Antitumor Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Targeted Antitumor Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Targeted Antitumor Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Targeted Antitumor Drugs
1.2 Key Market Segments
1.2.1 Targeted Antitumor Drugs Segment by Type
1.2.2 Targeted Antitumor Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARGETED ANTITUMOR DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Targeted Antitumor Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Targeted Antitumor Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARGETED ANTITUMOR DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Targeted Antitumor Drugs Sales by Manufacturers (2019-2024)
3.2 Global Targeted Antitumor Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Targeted Antitumor Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Targeted Antitumor Drugs Sales Sites, Area Served, Product Type
3.6 Targeted Antitumor Drugs Market Competitive Situation and Trends
3.6.1 Targeted Antitumor Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Targeted Antitumor Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TARGETED ANTITUMOR DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Targeted Antitumor Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARGETED ANTITUMOR DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TARGETED ANTITUMOR DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Antitumor Drugs Sales Market Share by Type (2019-2024)
6.3 Global Targeted Antitumor Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Targeted Antitumor Drugs Price by Type (2019-2024)
7 TARGETED ANTITUMOR DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Antitumor Drugs Market Sales by Application (2019-2024)
7.3 Global Targeted Antitumor Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Targeted Antitumor Drugs Sales Growth Rate by Application (2019-2024)
8 TARGETED ANTITUMOR DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Targeted Antitumor Drugs Sales by Region
8.1.1 Global Targeted Antitumor Drugs Sales by Region
8.1.2 Global Targeted Antitumor Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Targeted Antitumor Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Targeted Antitumor Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Targeted Antitumor Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Targeted Antitumor Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Targeted Antitumor Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Targeted Antitumor Drugs Basic Information
9.1.2 Roche Targeted Antitumor Drugs Product Overview
9.1.3 Roche Targeted Antitumor Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Targeted Antitumor Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Targeted Antitumor Drugs Basic Information
9.2.2 Celgene Targeted Antitumor Drugs Product Overview
9.2.3 Celgene Targeted Antitumor Drugs Product Market Performance
9.2.4 Celgene Business Overview
9.2.5 Celgene Targeted Antitumor Drugs SWOT Analysis
9.2.6 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Targeted Antitumor Drugs Basic Information
9.3.2 Novartis Targeted Antitumor Drugs Product Overview
9.3.3 Novartis Targeted Antitumor Drugs Product Market Performance
9.3.4 Novartis Targeted Antitumor Drugs SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Targeted Antitumor Drugs Basic Information
9.4.2 Johnson and Johnson Targeted Antitumor Drugs Product Overview
9.4.3 Johnson and Johnson Targeted Antitumor Drugs Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Lilly
9.5.1 Lilly Targeted Antitumor Drugs Basic Information
9.5.2 Lilly Targeted Antitumor Drugs Product Overview
9.5.3 Lilly Targeted Antitumor Drugs Product Market Performance
9.5.4 Lilly Business Overview
9.5.5 Lilly Recent Developments
9.6 AstraZeneca plc.
9.6.1 AstraZeneca plc. Targeted Antitumor Drugs Basic Information
9.6.2 AstraZeneca plc. Targeted Antitumor Drugs Product Overview
9.6.3 AstraZeneca plc. Targeted Antitumor Drugs Product Market Performance
9.6.4 AstraZeneca plc. Business Overview
9.6.5 AstraZeneca plc. Recent Developments
9.7 Betta Pharmaceuticals
9.7.1 Betta Pharmaceuticals Targeted Antitumor Drugs Basic Information
9.7.2 Betta Pharmaceuticals Targeted Antitumor Drugs Product Overview
9.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Product Market Performance
9.7.4 Betta Pharmaceuticals Business Overview
9.7.5 Betta Pharmaceuticals Recent Developments
9.8 Shanghai Henlius Biopharmaceutical
9.8.1 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Basic Information
9.8.2 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Overview
9.8.3 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Market Performance
9.8.4 Shanghai Henlius Biopharmaceutical Business Overview
9.8.5 Shanghai Henlius Biopharmaceutical Recent Developments
9.9 Innovent Biologics
9.9.1 Innovent Biologics Targeted Antitumor Drugs Basic Information
9.9.2 Innovent Biologics Targeted Antitumor Drugs Product Overview
9.9.3 Innovent Biologics Targeted Antitumor Drugs Product Market Performance
9.9.4 Innovent Biologics Business Overview
9.9.5 Innovent Biologics Recent Developments
9.10 Nanjing Shunxin Pharmaceuticals
9.10.1 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Basic Information
9.10.2 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Overview
9.10.3 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Market Performance
9.10.4 Nanjing Shunxin Pharmaceuticals Business Overview
9.10.5 Nanjing Shunxin Pharmaceuticals Recent Developments
9.11 CSPC OUYI Pharmaceutical
9.11.1 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Basic Information
9.11.2 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Overview
9.11.3 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Market Performance
9.11.4 CSPC OUYI Pharmaceutical Business Overview
9.11.5 CSPC OUYI Pharmaceutical Recent Developments
9.12 Qilu Pharmaceutical
9.12.1 Qilu Pharmaceutical Targeted Antitumor Drugs Basic Information
9.12.2 Qilu Pharmaceutical Targeted Antitumor Drugs Product Overview
9.12.3 Qilu Pharmaceutical Targeted Antitumor Drugs Product Market Performance
9.12.4 Qilu Pharmaceutical Business Overview
9.12.5 Qilu Pharmaceutical Recent Developments
9.13 Shenzhen Salubris Pharmaceuticals
9.13.1 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Basic Information
9.13.2 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Overview
9.13.3 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Market Performance
9.13.4 Shenzhen Salubris Pharmaceuticals Business Overview
9.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments
9.14 Yaopharma
9.14.1 Yaopharma Targeted Antitumor Drugs Basic Information
9.14.2 Yaopharma Targeted Antitumor Drugs Product Overview
9.14.3 Yaopharma Targeted Antitumor Drugs Product Market Performance
9.14.4 Yaopharma Business Overview
9.14.5 Yaopharma Recent Developments
9.15 Lianyungang Runzhong Pharmaceutical
9.15.1 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Basic Information
9.15.2 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Overview
9.15.3 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Market Performance
9.15.4 Lianyungang Runzhong Pharmaceutical Business Overview
9.15.5 Lianyungang Runzhong Pharmaceutical Recent Developments
10 TARGETED ANTITUMOR DRUGS MARKET FORECAST BY REGION
10.1 Global Targeted Antitumor Drugs Market Size Forecast
10.2 Global Targeted Antitumor Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Targeted Antitumor Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Targeted Antitumor Drugs Market Size Forecast by Region
10.2.4 South America Targeted Antitumor Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Targeted Antitumor Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Targeted Antitumor Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Targeted Antitumor Drugs by Type (2025-2030)
11.1.2 Global Targeted Antitumor Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Targeted Antitumor Drugs by Type (2025-2030)
11.2 Global Targeted Antitumor Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Targeted Antitumor Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Targeted Antitumor Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Targeted Antitumor Drugs Market Size Comparison by Region (M USD)
Table 5. Global Targeted Antitumor Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Targeted Antitumor Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Targeted Antitumor Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Targeted Antitumor Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Antitumor Drugs as of 2022)
Table 10. Global Market Targeted Antitumor Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Targeted Antitumor Drugs Sales Sites and Area Served
Table 12. Manufacturers Targeted Antitumor Drugs Product Type
Table 13. Global Targeted Antitumor Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Targeted Antitumor Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Targeted Antitumor Drugs Market Challenges
Table 22. Global Targeted Antitumor Drugs Sales by Type (Kilotons)
Table 23. Global Targeted Antitumor Drugs Market Size by Type (M USD)
Table 24. Global Targeted Antitumor Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Targeted Antitumor Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Targeted Antitumor Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Targeted Antitumor Drugs Market Size Share by Type (2019-2024)
Table 28. Global Targeted Antitumor Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Targeted Antitumor Drugs Sales (Kilotons) by Application
Table 30. Global Targeted Antitumor Drugs Market Size by Application
Table 31. Global Targeted Antitumor Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Targeted Antitumor Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Targeted Antitumor Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Targeted Antitumor Drugs Market Share by Application (2019-2024)
Table 35. Global Targeted Antitumor Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Targeted Antitumor Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Targeted Antitumor Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Targeted Antitumor Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Targeted Antitumor Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Targeted Antitumor Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Targeted Antitumor Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Targeted Antitumor Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Targeted Antitumor Drugs Basic Information
Table 44. Roche Targeted Antitumor Drugs Product Overview
Table 45. Roche Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Targeted Antitumor Drugs SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Celgene Targeted Antitumor Drugs Basic Information
Table 50. Celgene Targeted Antitumor Drugs Product Overview
Table 51. Celgene Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Celgene Business Overview
Table 53. Celgene Targeted Antitumor Drugs SWOT Analysis
Table 54. Celgene Recent Developments
Table 55. Novartis Targeted Antitumor Drugs Basic Information
Table 56. Novartis Targeted Antitumor Drugs Product Overview
Table 57. Novartis Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Targeted Antitumor Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Johnson and Johnson Targeted Antitumor Drugs Basic Information
Table 62. Johnson and Johnson Targeted Antitumor Drugs Product Overview
Table 63. Johnson and Johnson Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Lilly Targeted Antitumor Drugs Basic Information
Table 67. Lilly Targeted Antitumor Drugs Product Overview
Table 68. Lilly Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Lilly Business Overview
Table 70. Lilly Recent Developments
Table 71. AstraZeneca plc. Targeted Antitumor Drugs Basic Information
Table 72. AstraZeneca plc. Targeted Antitumor Drugs Product Overview
Table 73. AstraZeneca plc. Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca plc. Business Overview
Table 75. AstraZeneca plc. Recent Developments
Table 76. Betta Pharmaceuticals Targeted Antitumor Drugs Basic Information
Table 77. Betta Pharmaceuticals Targeted Antitumor Drugs Product Overview
Table 78. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Betta Pharmaceuticals Business Overview
Table 80. Betta Pharmaceuticals Recent Developments
Table 81. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Basic Information
Table 82. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Overview
Table 83. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Shanghai Henlius Biopharmaceutical Business Overview
Table 85. Shanghai Henlius Biopharmaceutical Recent Developments
Table 86. Innovent Biologics Targeted Antitumor Drugs Basic Information
Table 87. Innovent Biologics Targeted Antitumor Drugs Product Overview
Table 88. Innovent Biologics Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Innovent Biologics Business Overview
Table 90. Innovent Biologics Recent Developments
Table 91. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Basic Information
Table 92. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Overview
Table 93. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Nanjing Shunxin Pharmaceuticals Business Overview
Table 95. Nanjing Shunxin Pharmaceuticals Recent Developments
Table 96. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Basic Information
Table 97. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Overview
Table 98. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CSPC OUYI Pharmaceutical Business Overview
Table 100. CSPC OUYI Pharmaceutical Recent Developments
Table 101. Qilu Pharmaceutical Targeted Antitumor Drugs Basic Information
Table 102. Qilu Pharmaceutical Targeted Antitumor Drugs Product Overview
Table 103. Qilu Pharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Qilu Pharmaceutical Business Overview
Table 105. Qilu Pharmaceutical Recent Developments
Table 106. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Basic Information
Table 107. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Overview
Table 108. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Shenzhen Salubris Pharmaceuticals Business Overview
Table 110. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 111. Yaopharma Targeted Antitumor Drugs Basic Information
Table 112. Yaopharma Targeted Antitumor Drugs Product Overview
Table 113. Yaopharma Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Yaopharma Business Overview
Table 115. Yaopharma Recent Developments
Table 116. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Basic Information
Table 117. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Overview
Table 118. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Lianyungang Runzhong Pharmaceutical Business Overview
Table 120. Lianyungang Runzhong Pharmaceutical Recent Developments
Table 121. Global Targeted Antitumor Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Targeted Antitumor Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Targeted Antitumor Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Targeted Antitumor Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Targeted Antitumor Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Targeted Antitumor Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Targeted Antitumor Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Targeted Antitumor Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Targeted Antitumor Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Targeted Antitumor Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Targeted Antitumor Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Targeted Antitumor Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Targeted Antitumor Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Targeted Antitumor Drugs Market Size Comparison by Region (M USD)
Table 5. Global Targeted Antitumor Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Targeted Antitumor Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Targeted Antitumor Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Targeted Antitumor Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Antitumor Drugs as of 2022)
Table 10. Global Market Targeted Antitumor Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Targeted Antitumor Drugs Sales Sites and Area Served
Table 12. Manufacturers Targeted Antitumor Drugs Product Type
Table 13. Global Targeted Antitumor Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Targeted Antitumor Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Targeted Antitumor Drugs Market Challenges
Table 22. Global Targeted Antitumor Drugs Sales by Type (Kilotons)
Table 23. Global Targeted Antitumor Drugs Market Size by Type (M USD)
Table 24. Global Targeted Antitumor Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Targeted Antitumor Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Targeted Antitumor Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Targeted Antitumor Drugs Market Size Share by Type (2019-2024)
Table 28. Global Targeted Antitumor Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Targeted Antitumor Drugs Sales (Kilotons) by Application
Table 30. Global Targeted Antitumor Drugs Market Size by Application
Table 31. Global Targeted Antitumor Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Targeted Antitumor Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Targeted Antitumor Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Targeted Antitumor Drugs Market Share by Application (2019-2024)
Table 35. Global Targeted Antitumor Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Targeted Antitumor Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Targeted Antitumor Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Targeted Antitumor Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Targeted Antitumor Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Targeted Antitumor Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Targeted Antitumor Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Targeted Antitumor Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Targeted Antitumor Drugs Basic Information
Table 44. Roche Targeted Antitumor Drugs Product Overview
Table 45. Roche Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Targeted Antitumor Drugs SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Celgene Targeted Antitumor Drugs Basic Information
Table 50. Celgene Targeted Antitumor Drugs Product Overview
Table 51. Celgene Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Celgene Business Overview
Table 53. Celgene Targeted Antitumor Drugs SWOT Analysis
Table 54. Celgene Recent Developments
Table 55. Novartis Targeted Antitumor Drugs Basic Information
Table 56. Novartis Targeted Antitumor Drugs Product Overview
Table 57. Novartis Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Targeted Antitumor Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Johnson and Johnson Targeted Antitumor Drugs Basic Information
Table 62. Johnson and Johnson Targeted Antitumor Drugs Product Overview
Table 63. Johnson and Johnson Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Lilly Targeted Antitumor Drugs Basic Information
Table 67. Lilly Targeted Antitumor Drugs Product Overview
Table 68. Lilly Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Lilly Business Overview
Table 70. Lilly Recent Developments
Table 71. AstraZeneca plc. Targeted Antitumor Drugs Basic Information
Table 72. AstraZeneca plc. Targeted Antitumor Drugs Product Overview
Table 73. AstraZeneca plc. Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca plc. Business Overview
Table 75. AstraZeneca plc. Recent Developments
Table 76. Betta Pharmaceuticals Targeted Antitumor Drugs Basic Information
Table 77. Betta Pharmaceuticals Targeted Antitumor Drugs Product Overview
Table 78. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Betta Pharmaceuticals Business Overview
Table 80. Betta Pharmaceuticals Recent Developments
Table 81. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Basic Information
Table 82. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Overview
Table 83. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Shanghai Henlius Biopharmaceutical Business Overview
Table 85. Shanghai Henlius Biopharmaceutical Recent Developments
Table 86. Innovent Biologics Targeted Antitumor Drugs Basic Information
Table 87. Innovent Biologics Targeted Antitumor Drugs Product Overview
Table 88. Innovent Biologics Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Innovent Biologics Business Overview
Table 90. Innovent Biologics Recent Developments
Table 91. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Basic Information
Table 92. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Overview
Table 93. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Nanjing Shunxin Pharmaceuticals Business Overview
Table 95. Nanjing Shunxin Pharmaceuticals Recent Developments
Table 96. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Basic Information
Table 97. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Overview
Table 98. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CSPC OUYI Pharmaceutical Business Overview
Table 100. CSPC OUYI Pharmaceutical Recent Developments
Table 101. Qilu Pharmaceutical Targeted Antitumor Drugs Basic Information
Table 102. Qilu Pharmaceutical Targeted Antitumor Drugs Product Overview
Table 103. Qilu Pharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Qilu Pharmaceutical Business Overview
Table 105. Qilu Pharmaceutical Recent Developments
Table 106. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Basic Information
Table 107. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Overview
Table 108. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Shenzhen Salubris Pharmaceuticals Business Overview
Table 110. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 111. Yaopharma Targeted Antitumor Drugs Basic Information
Table 112. Yaopharma Targeted Antitumor Drugs Product Overview
Table 113. Yaopharma Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Yaopharma Business Overview
Table 115. Yaopharma Recent Developments
Table 116. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Basic Information
Table 117. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Overview
Table 118. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Lianyungang Runzhong Pharmaceutical Business Overview
Table 120. Lianyungang Runzhong Pharmaceutical Recent Developments
Table 121. Global Targeted Antitumor Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Targeted Antitumor Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Targeted Antitumor Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Targeted Antitumor Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Targeted Antitumor Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Targeted Antitumor Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Targeted Antitumor Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Targeted Antitumor Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Targeted Antitumor Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Targeted Antitumor Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Targeted Antitumor Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Targeted Antitumor Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Targeted Antitumor Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Targeted Antitumor Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Targeted Antitumor Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Antitumor Drugs Market Size (M USD), 2019-2030
Figure 5. Global Targeted Antitumor Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Targeted Antitumor Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Antitumor Drugs Market Size by Country (M USD)
Figure 11. Targeted Antitumor Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Targeted Antitumor Drugs Revenue Share by Manufacturers in 2023
Figure 13. Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Targeted Antitumor Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Targeted Antitumor Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Targeted Antitumor Drugs Market Share by Type
Figure 18. Sales Market Share of Targeted Antitumor Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Targeted Antitumor Drugs by Type in 2023
Figure 20. Market Size Share of Targeted Antitumor Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Targeted Antitumor Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Targeted Antitumor Drugs Market Share by Application
Figure 24. Global Targeted Antitumor Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Targeted Antitumor Drugs Sales Market Share by Application in 2023
Figure 26. Global Targeted Antitumor Drugs Market Share by Application (2019-2024)
Figure 27. Global Targeted Antitumor Drugs Market Share by Application in 2023
Figure 28. Global Targeted Antitumor Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Targeted Antitumor Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Targeted Antitumor Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Targeted Antitumor Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Targeted Antitumor Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Targeted Antitumor Drugs Sales Market Share by Country in 2023
Figure 37. Germany Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Targeted Antitumor Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Targeted Antitumor Drugs Sales Market Share by Region in 2023
Figure 44. China Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Targeted Antitumor Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Targeted Antitumor Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Targeted Antitumor Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Targeted Antitumor Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Targeted Antitumor Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Targeted Antitumor Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Targeted Antitumor Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Targeted Antitumor Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Targeted Antitumor Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Targeted Antitumor Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Targeted Antitumor Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Antitumor Drugs Market Size (M USD), 2019-2030
Figure 5. Global Targeted Antitumor Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Targeted Antitumor Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Antitumor Drugs Market Size by Country (M USD)
Figure 11. Targeted Antitumor Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Targeted Antitumor Drugs Revenue Share by Manufacturers in 2023
Figure 13. Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Targeted Antitumor Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Targeted Antitumor Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Targeted Antitumor Drugs Market Share by Type
Figure 18. Sales Market Share of Targeted Antitumor Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Targeted Antitumor Drugs by Type in 2023
Figure 20. Market Size Share of Targeted Antitumor Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Targeted Antitumor Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Targeted Antitumor Drugs Market Share by Application
Figure 24. Global Targeted Antitumor Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Targeted Antitumor Drugs Sales Market Share by Application in 2023
Figure 26. Global Targeted Antitumor Drugs Market Share by Application (2019-2024)
Figure 27. Global Targeted Antitumor Drugs Market Share by Application in 2023
Figure 28. Global Targeted Antitumor Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Targeted Antitumor Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Targeted Antitumor Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Targeted Antitumor Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Targeted Antitumor Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Targeted Antitumor Drugs Sales Market Share by Country in 2023
Figure 37. Germany Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Targeted Antitumor Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Targeted Antitumor Drugs Sales Market Share by Region in 2023
Figure 44. China Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Targeted Antitumor Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Targeted Antitumor Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Targeted Antitumor Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Targeted Antitumor Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Targeted Antitumor Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Targeted Antitumor Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Targeted Antitumor Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Targeted Antitumor Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Targeted Antitumor Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Targeted Antitumor Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Targeted Antitumor Drugs Market Share Forecast by Application (2025-2030)